FREDERICK, MARYLAND, JULY 27, 2020: BioFactura, Inc. today announced a $1 million Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). The goal of this project is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid manufacture of a monoclonal antibody (mAb) therapeutic against the Marburg virus (MARV) biothreat. ...  Read more

Columbia-based KatzAbosch has released a Medical Community COVID-19 Survey to get a sense of how medical practices are responding to the COVID-19 crisis. The firm asked approached its medical clients and contacts to participate in this peer survey in order to provide general benchmarking data to the community and all local practices around the impact COVID-19 has had on the medical industry. ...  Read more

GLEN BURNIE, MD, July 13, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, is helping companies prepare for employees to return to work safely and securely. As organizations implement Return to Work (RTW) strategies in the face of the global pandemic, a Screening, Protection and Tracing (SPT) plan is critical to protecting employees, visitors, and the broader community. The plan needs to be flexible, yet in accordance with state and local regulations and recommendations. ...  Read more

Hunt Valley, MD – February 24, 2019 – Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) today announced it has won four CMO Leadership Awards. The Awards, presented by Life Science Leader and based on research conducted by ISR, recognizes top outsourcing partners, determined by feedback from sponsor companies who outsource manufacturing. Pii won the awards for Compatibility (Big Pharma), Quality (Overall, Big Pharma), Reliability (Overall, Big Pharma) and Service (Overall).  Pii will accept their awards at the CMO Leadership Awards Ceremony on March 25^th. ...  Read more

VHEPC approval allows Mavenspire to help Virginia’s educational, healthcare and governmental institutions harness their data. ...  Read more

ROCKVILLE, Md. & SAN DIEGO–(BUSINESS WIRE)–Replicate Bioscience, Inc. (“Replicate”), a privately-held biopharmaceutical company creating novel treatments to prevent drug resistance in cancers, and Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that the companies have entered into a research and licensing option agreement to combine their platform technologies to combat infectious diseases and cancers. ...  Read more

Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr^® platform license and supply agreement, plus successful production of multiple batches of Sirnaomics drug product candidates, STP705 and STP707, for ongoing IND enabling safety and toxicity studies, as well as several clinical studies. ...  Read more

23rd June 2020, Frederick, Maryland, — Kemp Proteins, a leading provider of gene-to-protein and monoclonal antibody development services, today announced that the company has received ISO9001:2015 certification for the development and manufacturing of protein-based products and services to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to a culture of continuous improvement focused on providing clients with world-class protein development services. ...  Read more